Nerissa Kreher insider trades

Open-market stock purchases and sales by Nerissa Kreher, Director at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Oct 8, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +19%.

Recent trades

DateStockTradeValue
Jul 1, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jul 1, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)$303K
Nov 19, 2025RZLT Rezolute, IncBought (not open market)—
Nov 19, 2025RZLT Rezolute, IncBought (not open market)—

Companies traded

  • XERS Xeris Biopharma Holdings, Inc: other filings, last Jul 1, 2026
  • RZLT Rezolute, Inc: 1 buy, last Nov 19, 2025
  • TRDA Entrada Therapeutics, Inc: 24 sales, last Sep 6, 2023
  • AVRO AVROBIO, Inc: other filings, last Oct 8, 2018

Get free alerts when Nerissa Kreher files a new trade →